# FDA Inspection 1171889 - Biomat USA, Inc. - May 20, 2022

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b2a0cbf5-bbcb-4544-93e5-664068d46485
Source feed: FDA_Inspections

> FDA Inspection 1171889 for Biomat USA, Inc. on May 20, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1171889
- Company Name: Biomat USA, Inc.
- Inspection Date: 2022-05-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1171889 - 2022-05-20](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/78cedebd-156f-4c1b-9cf9-2a348fdf5ab2)

Company: https://www.keypedia.com/companies/biomat-usa-inc/104369f0-4193-433f-8928-786c854e5665

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d